Showing posts with label APAC AI Healthcare Market. Show all posts
Showing posts with label APAC AI Healthcare Market. Show all posts

Tuesday, February 4, 2020

APAC AI in Healthcare Market driven by Government Initiatives, Investments & Collaborations in the Sector, Emergence of New Startups, Increasing Adoption of Healthcare AI Technology in Developing Countries: Ken Research

APAC AI in Healthcare Market has been facilitated by increasing awareness about the application of artificial intelligence in healthcare which will further be complemented by supportive legislation and regulations. It is necessary for investors and end-users to know that AI-enabled knowledge management does not necessitate the replacement of human experts. Rather, the errands are supposed to be executed by human experts with the support of AI-enabled services. Moreover, the need of the hour in the coming years shall revolve around the need to digitalize every physical field datasets which would then be integrated with online datasets to explore the full customer journey with AI-enabled solutions. There is a call for managing excess of services with different parties to unlock the virtual assistant to execute more complicated and intuitive tasks.
The major growth in the APAC region can be accredited to Japan with the presence of high-level R&D Infrastructure and government initiatives including Japan Revitalization Strategy, Robotic Care Equipment Development and Introduction Project, Jisedai Iryo-kiban and others. However, with growing Chinese AI startups, China is expected to lead the way by 2025.
A notable increase in the efficiency of medical procedures and diagnosis can be seen with increased AI applications in processes such as clinical trials, drug discovery, robot assisted surgeries and others.
APAC AI Healthcare Market
Pharmaceutical companies have been one of the key end-user segments to take interest in AI. Some of the software used by Pharmaceutical companies in drug development includes Deep 6 AI software, Edge CTMS, MasterControl CQMS, OpenClinica, Clinical Research IO, LifeSphere CTMS and others.
The major companies competing in the market were observed to be IBM, Intel, Microsoft Corporation, NIVEDIA Corp, iCarbonX, Oncora Medical, Alphabet Inc., Next IT Verint Corporation, Welltok Incorporation in 2018.
As per the Research Analyst from Ken Research, “A noted gap in demand and supply of skilled human resources for the medical sector can be observed thereby making it one of the major factors driving the need for AI in the healthcare industry. The case has been more severe in rural regions of developing countries like India, Indonesia, and the Philippines. AI applications in assisting surgeries, medical diagnosis and the overall record keeping have helped replace the lack of doctors and skilled healthcare professionals in these areas.”
“AI growth is expected to burst in the future wherein it is expected to over capture the market. The incorporation and use cases of AI healthcare have a lot of potentials thus making it talk of the future and technology of the future healthcare industry.”-Swarn Prakash, AI Healthcare Industry Expert
Key Segments Covered in APAC AI in Healthcare Market:-
By Technology (On the basis of Revenue)
Deep Learning Method
Querying Method
Natural Language Processing
Context-Aware Processing
By Application (On the basis of Revenue)
Machine/Robot Assisted Medical Procedures
Clinical Trial & Drug Discovery/Development
Preliminary Diagnosis
Administrative Workflow Assistance
Virtual Nursing Assistant
Fraud Detection
Dosage Error Reduction
Others (including Fitness & Wellness Tech (Physical Fitness, Mind & Body Wellness)
By End Users (On the basis of Revenue)
Hospitals/Clinics/Healthcare Providers
Medical Devices Companies
Pharmaceuticals & Biotechnology Companies
Others Including Payers and Other Software Providers
By Country (On the basis of Revenue)
Japan
China
Australia
India
Singapore
Rest of APAC
Key Target Audience
Hospitals, Clinics, and Healthcare Providers
Medical Device Manufacturers
Insurance Providers
AI Developers
Healthcare Software Providers
Pharmaceuticals & Biotechnology Companies
Research Institutes
Venture Capital Firms
Time Period Captured in the Report:
Historical Period – 2013-2018
Forecast Period – 2019-2025
Companies Covered:
IBM
NVIDIA Corporation
Intel
Microsoft Corporation
iCarbonX
Alphabet Inc.
Next IT Verint Corporation
Welltok Incorporation
Oncora Medical
Entilic Incorporation
Koninklijke Philips
General Vision
Key Topics Covered in the Report:-
APAC AI in Healthcare Value Chain & Ecosystem
APAC AI in Healthcare Market Size Analysis, 2013– 2018
APAC Healthcare AI Market Segmentation, 2013-2025E
Innovation, Adoption and Application Gap - Comparison of APAC with Europe & US
Regulatory Framework in APAC AI in Healthcare Market
Case Studies on Various Application Areas of AI in Healthcare, 2013-2018
Competitive Landscape in APAC AI in Healthcare Market, 2018
Company Profiling Of Major Players Operating in APAC Artificial Intelligence in Healthcare Market
Investment Scenario- Healthcare in AI, 2018
Taxonomy
Markets of Investment Activity
Future Market Sizing Analysis, 2019E-2025E
For More Information On The Research Report, Refer To Below Link:-
Related Reports by Ken Research:-
Contact Us:-Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Monday, February 3, 2020

APAC Healthcare AI Market Research Report to 2025: Ken Research

How is the AI in Healthcare Market Positioned in Asia Pacific? What are the Major Market Trends Driving the Industry?
The APAC AI in Healthcare Market is currently at its growth stage. Rising investments and entry of new global players has been complimenting the size of this industry. In terms of revenue, APAC AI in Healthcare market size was witnessed to increase from USD ~ million in the year 2013 to USD ~ million in 2018, therefore showcasing a CAGR of ~% over the review period 2013-2018. In Asia Pacific region, Japan is seen to be the market leader in terms of advancement and innovation as the region fosters leading companies, developed infrastructure & expanding demand. The demand for artificial intelligence in healthcare services in countries such as India, Japan and China has also been complemented by ever increasing rate of population. Rising number of investments, collaborations and partnerships among hospital chains, AI developers, medical device manufacturers and other healthcare providers has been one of the major factors that has led to coming up of various new small and medium sized AI developing companies in Asia Pacific region. In collaboration with various hospitals and medical device manufacturers, AI developing companies are also investing in providing training for implementing efficient usage of AI in medical devices and other administrative systems. There are two prominent pillars justifying 10 folds growth of AI in Healthcare services in APAC region. First is the state of medical infrastructure (that constitutes the medical equipments and devices, process/procedures and other automation techniques). In countries such as India and China, tremendous amount of improvement has been seen in terms of medical infrastructure which has made incorporation of AI in a smooth manner. Second factor is lack of available trained medical staff/professionals in various countries which has given birth to necessity in terms of automation of regular mundane tasks in hospitals administration and day to day functioning.

What are the various segmentations on which APAC AI Healthcare Market is divided?
APAC AI in Healthcare Market can typically be segmented on the basis of Technology, Applications, End Users and Country.
By Technology: APAC AI in Healthcare market incorporates technologies such as Deep Learning Method, Querying Method, Natural Language Processing and Context Aware Processing Method. Growth rate of Deep Learning Method was witnessed to be the highest during 2013-18, whereas Natural Language Processing had the highest market share, owing to its high application in data mining and image recognition systems and services.

By Application: Application areas include Machine/Robot Assisted Medical Procedures, Clinical Trial & Drug Discovery, Preliminary Diagnosis, Administrative Workflow Assistance, Virtual Nursing Assistant, Fraud Detection, Dosage Error Reduction and Others (including Fitness & Wellness Tech Devices). In 2018, machine or robot assisted surgeries were reported to be highest contributor to overall revenue generation, owing to high average cost of robots and increased adoption in past few years. After Machine/Robot Assisted Medical Procedures, second highest share in revenue contribution was occupied by Clinical Trial & Drug Discovery and Preliminary Diagnosis with revenue generation of about USD ~ million owing to its high application in several medicinal areas.

By End Users: In terms of end users, APAC AI in Healthcare market is categorized basis Hospitals, Clinics, Healthcare Providers, Medical Devices Companies, Pharmaceuticals & Biotechnology Companies and Others including Payers and Other Software Providers. In 2018, Healthcare Providers (including Hospitals and Clinics) contributed highest amount of revenue of about USD ~ Million. Factors driving demand in Hospitals and healthcare centers were high application of AI in overall management of hospitals through usage of several healthcare management software, high adoption of AI in medical devices & machineries used in hospitals, AI being used for mundane tasks in order to reduce workload of doctors and others. After Hospitals and Healthcare Centers, Medical Devices such as ultrasound device and machines used in detecting cardiovascular diseases and others were highest contributors to revenue.

By Country: In APAC region, Japan is seen to be one of the fastest growing market in terms of technological developments and innovations owing to its highly refined infrastructure for research and development with presence of numerous healthcare universities and industries and increasing investment due to government support.

Key Segments Covered in APAC AI in Healthcare Market
By Technology (On the basis of Revenue)
Deep Learning Method
Querying Method
Natural Language Processing
Context Aware Processing

By Application (On the basis of Revenue)
Machine/Robot Assisted Medical Procedures
Clinical Trial & Drug Discovery/Development
Preliminary Diagnosis
Administrative Workflow Assistance
Virtual Nursing Assistant
Fraud Detection
Dosage Error Reduction
Others (including Fitness & Wellness Tech (Physical Fitness, Mind & Body Wellness)

By End Users (On the basis of Revenue)
Hospitals/Clinics/Healthcare Providers
Medical Devices Companies
Pharmaceuticals & Biotechnology Companies
Others Including Payers and Other Software Providers

By Country (On the basis of Revenue)
Japan
China
Australia
India
Singapore
Rest of APAC

Key Target Audience
Hospitals, Clinics and Healthcare Providers
Medical Device Manufacturers
Insurance Providers
AI Developers
Healthcare Software Providers
Pharmaceuticals & Biotechnology Companies
Research Institutes
Venture Capital Firms

Time Period Captured in the Report:
Historical Period – 2013-2018
Forecast Period – 2019-2025

Companies Covered:
IBM
NVIDIA Corporation
Intel
Microsoft Corporation
iCarbonX
Alphabet Inc.
Next IT Verint Corporation
Welltok Incorporation
Oncora Medical
Entilic Incorporation
Koninklijke Philips
General Vision

Key Topics Covered in the Report
APAC AI in Healthcare Value Chain & Ecosystem
APAC AI in Healthcare Market Size Analysis, 2013– 2018
APAC Healthcare AI Market Segmentation, 2013-2025E
Innovation, Adoption and Application Gap - Comparison of APAC with Europe & US
Regulatory Framework in APAC AI in Healthcare Market
Case Studies on Various Application Areas of AI in Healthcare, 2013-2018
Competitive Landscape in APAC AI in Healthcare Market, 2018
Company Profiling Of Major Players Operating in APAC Artificial Intelligence in Healthcare Market
Investment Scenario- Healthcare in AI, 2018
Taxonomy
Markets of Investment Activity
Future Market Sizing Analysis, 2019E-2025E

For more information, refer to below link:

Related Reports


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249

Thursday, August 29, 2019

APAC AI in Healthcare Market is Driven by Advancement of Big Data Analytics, Limited Number of Skilled Healthcare Professionals, Increased Accuracy and Predictability in AI Applications: Ken Research Analysis

Increase in number of investments, advancements in processor designs, supportive legislatives & regulations and entry of global players in the market will be the key factors driving growth in APAC AI in Healthcare Market.

Rise in the Number of Collaborations, Investments & Partnerships: Several companies, hospitals and chain of clinics in APAC have started collaborating, after witnessing the rising benefits of using AI including superior customer experience. On the company front, AI has led to improved efficiency to diagnose and treat various diseases.  Moreover, rise in incidence of chronic diseases and increase in geriatric population has provided major boost to the demand for AI in the healthcare sector.  The surfacing of start-ups in the AI space has intensified competition in the market. This has given rise to the progress of the technology in a more cost effective manner. Healthcare companies were seen leveraging the benefits of the technology by simply acquiring start-up companies rather than developing the technology from scratch. For instance, Cardio-track has partnered with Columbia Asia Hospitals in Bangalore in August 2017 to provide AI-based devices that can be used to predict and diagnose cardiac diseases and disorders.

Supportive Legislations & Regulations: Government of countries such as China, Japan and India have been continuously investing their resources to promote development and usage of artificial intelligence services in healthcare and other sectors. In 2017, State Council of China released the Next Generation Artificial Intelligence Development Plan (Development Plan) with aim of developing regulatory system, strengthening intellectual property protection and promotion of AI development in China. The development plan is comprised of three stages i.e. 2020, 2025 and 2030 with goals for every stage. Apart from this, the government also provides various incentives such as tax reduction, low interest rate loans for setup costs and others to promote AI development centres in the country. Government of India developed Artificial Intelligence Task Force for enabling creation of an inter-ministerial National AI mission for coordination of AI related activities in country. These initiatives have played a huge role in bringing development and innovation to artificial intelligence services in healthcare market in these regions.

Wider Acceptability: Players operating in the artificial intelligence healthcare market have consistently adopted innovative strategies in order to gain a competitive advantage. Companies have been trying to develop AI services wherein a single type of AI can be used in multiple medical devices thereby increasing its applications and ease of integration in current systems. Other competing parameters followed by major players include provision of customization services to clients, ease in usage and involvement of low operational cost.

Analysts at Ken Research in their latest publication “APAC Healthcare AI Market Outlook to 2025 – By Applications (Machine/Robot Assisted Medical Procedures, Clinical Trial & Drug Discovery/Development, Preliminary Diagnosis, Administrative Workflow Assistance, Virtual Nursing Assistant, Fraud Detection, Dosage Error Reduction), by Countries, by End Users & by Technologies and Current Investment Scenario” believes that an increase of investments in AI Healthcare and growing government initiatives in field of artificial intelligence and healthcare would surge the overall revenue generated in APAC AI in Healthcare market. The market has witnessed a positive CAGR of close to 56% in terms of revenue generated Artificial Intelligence Providers in Healthcare during the review period 2013-2018.

Key Segments Covered in APAC AI in Healthcare Market
By Technology (On the basis of Revenue)
Deep Learning Method
Querying Method
Natural Language Processing
Context Aware Processing

By Application (On the basis of Revenue)
Machine/Robot Assisted Medical Procedures
Clinical Trial & Drug Discovery/Development
Preliminary Diagnosis
Administrative Workflow Assistance
Virtual Nursing Assistant
Fraud Detection
Dosage Error Reduction
Others (including Fitness & Wellness Tech (Physical Fitness, Mind & Body Wellness)

By End Users (On the basis of Revenue)
Hospitals/Clinics/Healthcare Providers
Medical Devices Companies
Pharmaceuticals & Biotechnology Companies
Others Including Payers and Other Software Providers

By Country (On the basis of Revenue)
Japan
China
Australia
India
Singapore
Rest of APAC

Key Target Audience
Hospitals, Clinics and Healthcare Providers
Medical Device Manufacturers
Insurance Providers
AI Developers
Healthcare Software Providers
Pharmaceuticals & Biotechnology Companies
Research Institutes
Venture Capital Firms

Time Period Captured in the Report:
Historical Period – 2013-2018
Forecast Period – 2019-2025

Companies Covered:
IBM
NVIDIA Corporation
Intel
Microsoft Corporation
iCarbonX
Alphabet Inc.
Next IT Verint Corporation
Welltok Incorporation
Oncora Medical
Entilic Incorporation
Koninklijke Philips
General Vision

Key Topics Covered in the Report
APAC AI in Healthcare Value Chain & Ecosystem
APAC AI in Healthcare Market Size Analysis, 2013– 2018
APAC Healthcare AI Market Segmentation, 2013-2025E
Innovation, Adoption and Application Gap - Comparison of APAC with Europe & US
Regulatory Framework in APAC AI in Healthcare Market
Case Studies on Various Application Areas of AI in Healthcare, 2013-2018
Competitive Landscape in APAC AI in Healthcare Market, 2018
Company Profiling Of Major Players Operating in APAC Artificial Intelligence in Healthcare Market
Investment Scenario- Healthcare in AI, 2018
Taxonomy
Markets of Investment Activity
Future Market Sizing Analysis, 2019E-2025E

For more information, refer to below link:

Related Reports




Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249